A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor

por Hattori, Y, Du, W, Yamada, T, Ichikawa, D, Matsunami, S, Matsushita, M
Publicado 2013

Breast cancer diagnosis based on lipid profiling by probe electrospray ionization mass spectrometry

por Iwano, T., Yoshimura, K., Inoue, S., Odate, T., Ogata, K., Funatsu, S., Tanihata, H., Kondo, T., Ichikawa, D., Takeda, S.
Publicado 2020

Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma

por Toma, A, Otsuji, E, Kuriu, Y, Okamoto, K, Ichikawa, D, Hagiwara, A, Ito, H, Nishimura, T, Yamagishi, H
Publicado 2005

Analysis of histological therapeutic effect, apoptosis rate and p53 status after combined treatment with radiation, hyperthermia and 5-fluorouracil suppositories for advanced recta...

por Sakakura, C., Koide, K., Ichikawa, D., Wakasa, T., Shirasu, M., Kimura, A., Taniguchi, H., Hagiwara, A., Yamaguchi, T., Inazawa, J., Abe, T., Takahashi, T., Otsuji, E.
Publicado 1998

Circulating microRNAs in plasma of patients with gastric cancers

por Tsujiura, M, Ichikawa, D, Komatsu, S, Shiozaki, A, Takeshita, H, Kosuga, T, Konishi, H, Morimura, R, Deguchi, K, Fujiwara, H, Okamoto, K, Otsuji, E
Publicado 2010

Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma

por Takeshita, H, Ichikawa, D, Komatsu, S, Tsujiura, M, Kosuga, T, Deguchi, K, Konishi, H, Morimura, R, Shiozaki, A, Fujiwara, H, Okamoto, K, Otsuji, E
Publicado 2010

Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma

por Komatsu, S, Ichikawa, D, Hirajima, S, Kawaguchi, T, Miyamae, M, Okajima, W, Ohashi, T, Arita, T, Konishi, H, Shiozaki, A, Fujiwara, H, Okamoto, K, Yagi, N, Otsuji, E
Publicado 2014

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma

por Komatsu, S, Ichikawa, D, Takeshita, H, Tsujiura, M, Morimura, R, Nagata, H, Kosuga, T, Iitaka, D, Konishi, H, Shiozaki, A, Fujiwara, H, Okamoto, K, Otsuji, E
Publicado 2011

Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer

por Morimura, R, Komatsu, S, Ichikawa, D, Takeshita, H, Tsujiura, M, Nagata, H, Konishi, H, Shiozaki, A, Ikoma, H, Okamoto, K, Ochiai, T, Taniguchi, H, Otsuji, E
Publicado 2011

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma

por Konishi, H, Ichikawa, D, Komatsu, S, Shiozaki, A, Tsujiura, M, Takeshita, H, Morimura, R, Nagata, H, Arita, T, Kawaguchi, T, Hirashima, S, Fujiwara, H, Okamoto, K, Otsuji, E
Publicado 2012

Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma

por Hirajima, S, Komatsu, S, Ichikawa, D, Takeshita, H, Konishi, H, Shiozaki, A, Morimura, R, Tsujiura, M, Nagata, H, Kawaguchi, T, Arita, T, Kubota, T, Fujiwara, H, Okamoto, K, Otsuji, E
Publicado 2013

Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma

por Nishimura, Y, Komatsu, S, Ichikawa, D, Nagata, H, Hirajima, S, Takeshita, H, Kawaguchi, T, Arita, T, Konishi, H, Kashimoto, K, Shiozaki, A, Fujiwara, H, Okamoto, K, Tsuda, H, Otsuji, E
Publicado 2013

Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer

por Kawaguchi, T, Komatsu, S, Ichikawa, D, Morimura, R, Tsujiura, M, Konishi, H, Takeshita, H, Nagata, H, Arita, T, Hirajima, S, Shiozaki, A, Ikoma, H, Okamoto, K, Ochiai, T, Taniguchi, H, Otsuji, E
Publicado 2013

Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer

por Shitara, K, Yuki, S, Tahahari, D, Nakamura, M, Kondo, C, Tsuda, T, Kii, T, Tsuji, Y, Utsunomiya, S, Ichikawa, D, Hosokawa, A, Ishiguro, A, Sakai, D, Hironaka, S, Oze, I, Matsuo, K, Muro, K
Publicado 2014

Overexpression of SMYD2 contributes to malignant outcome in gastric cancer

por Komatsu, S, Ichikawa, D, Hirajima, S, Nagata, H, Nishimura, Y, Kawaguchi, T, Miyamae, M, Okajima, W, Ohashi, T, Konishi, H, Shiozaki, A, Fujiwara, H, Okamoto, K, Tsuda, H, Imoto, I, Inazawa, J, Otsuji, E
Publicado 2015

CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients

por Matsushita, M, Ozawa, K, Suzuki, T, Nakamura, M, Nakano, N, Kanchi, S, Ichikawa, D, Matsuki, E, Sakurai, M, Karigane, D, Kasahara, H, Tsukamoto, N, Shimizu, T, Mori, T, Nakajima, H, Okamoto, S, Kawakami, Y, Hattori, Y
Publicado 2017